Mylan Inc $52.34

up +0.28


23/7/2014 04:00 PM  |  NASDAQ : MYL  
Industries : Drugs / Drugs - Generic
Get Trend Analysis Icon Get MYL Trend Analysis - it has outperformed the S&P 500 by 45%

Partner Headlines

  1. Mylan Wins Motion For Temporary Restraining Order Against Apotex For Authorized ...

    Benzinga
  2. Will Congress Scuttle the AbbVie-Shire Merger?

    FoxBusiness
  3. Mylan Wins Motion To Enjoin GlaxoSmithKline From Providing Paroxetine CR ...

    Benzinga
  4. Abbott, St. Jude Top Views, But Stocks Under Pressure

    IBD
  5. Treasury Urges Halt to Tax Inversion M&A 'Abuse'

    IBD
  6. UPDATE: Bank Of America Reiterates On Mylan Following Abbott Transaction

    Benzinga
  7. AbbVie Near $54 Bil Shire Buy

    IBD
  8. Mylan, AbbVie News Shows Tax Inversion Boom Continues

    IBD
  9. Stocks Slip From Day's Highs; Kandi Zooms On Sales Report

    IBD
  10. Mylan Buying Abbott Generics Unit, Moving Abroad

    IBD
  11. Benzinga's Volume Movers

    Benzinga
  12. Morning Market Movers

    Benzinga
  13. Benzinga's Top #PreMarket Gainers

    Benzinga
  14. Novo, Other Medicals Display Healthy Action

    IBD
  15. Generic-Drug Makers Climb Ranks; Several In Buy Range

    IBD
  16. Wells Fargo Initiates Coverage On The Pharmaceutical Space

    Benzinga
  17. Mylan

    IBD
  18. Earnings Scheduled For May 1, 2014

    Benzinga
  19. Forest Acquiring Furiex To Boost GI Franchise

    IBD
  20. Stocks Open Up, Techs Stressed; March Pending Home Sales Soar

    IBD
  21. Morning Market Losers

    Benzinga
  22. Benzinga's Weekend M&A Chatter

    Benzinga
  23. Indexes Near Session Lows As Tech Stocks Are Routed

    IBD
  24. Mylan Raises Bid for Meda to 145 Kroner/Share, Shares Gain 3%

    Benzinga
  25. Mylan Shares Spike Higher; Hearing Chatter of New Meda Bid

    Benzinga
  26. Scott Black's Top First Quarter Holdings

    GuruFocus
  27. UPDATE: Mylan Launches First Generic ORTHO EVRA Patch

    Benzinga
  28. Mylan Launches Generic Lunesta Tablets

    Benzinga
  29. Mylan Says Judge Has Enforced Settlement Deal Between Mylan, Endo Related ...

    Benzinga
  30. Nasdaq Turns Solidly Higher in Volatile Action

    FoxBusiness
  31. Benzinga's Weekend M&A Chatter

    Benzinga
  32. Meda Rejects Mylan's Takeover Proposal

    Benzinga
  33. Meda Rejects Mylan's Bid

    IBD
  34. Mylan Bid Gets Rejected, But Generic-Drugmaker Rises

    IBD
  35. Mid-Afternoon Market Update: Markets Drop, Lead Lower by NASDAQ Momentum ...

    Benzinga
  36. Growth Names Pressured; Nasdaq Gives Up 50-Day Line

    IBD
  37. Mid-Day Market Update: NASDAQ Tumbles 1.8%; SYNNEX Shares Gain After Upbeat ...

    Benzinga
  38. Mylan Rejected In Bid To Acquire Sweden's Meda

    IBD
  39. Mid-Morning Market Update: Markets Mixed; CarMax Results Miss Estimates

    Benzinga
  40. Meda Board Issues Statement Confirming Contact by Mylan, Rejection of Proposal

    Benzinga
  41. Stock Futures Vector Higher; March Payrolls Report Mixed

    IBD
  42. Benzinga's Top #PreMarket Gainers

    Benzinga
  43. Mylan Considering Takeover of Sweden's Meda -FT

    Benzinga
  44. Which Pharmas Can Keep Up Dividend-Buybacks?

    YCharts
  45. Should You Buy Actavis?

    GuruFocus
  46. Horizon Pharma Banks On Two-For-One Arthritis Drugs

    IBD
  47. US Stock Futures Up Ahead Of Jobless Claims, Retail Sales Data

    Benzinga
  48. Pfizer Loses Patent On Celebrex, Plans To Appeal

    IBD
  49. Pfizer Loses Bid to Hold Celebrex Exclusivity to '15

    FoxBusiness
  50. Will Horizon Pharma Spike Again On Quarterly Report?

    IBD
Trading Center